M L Slevin

8.3k total citations · 1 hit paper
106 papers, 4.9k citations indexed

About

M L Slevin is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M L Slevin has authored 106 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 21 papers in Molecular Biology and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M L Slevin's work include Lung Cancer Research Studies (20 papers), Cancer therapeutics and mechanisms (15 papers) and Neuroendocrine Tumor Research Advances (13 papers). M L Slevin is often cited by papers focused on Lung Cancer Research Studies (20 papers), Cancer therapeutics and mechanisms (15 papers) and Neuroendocrine Tumor Research Advances (13 papers). M L Slevin collaborates with scholars based in United Kingdom, United States and Mexico. M L Slevin's co-authors include Peter Clark, W. Gregory, Richard J. Osborne, Richard H. Osborne, Simon Joel, Tim Lister, Peter Wilson, Hilary Plant, Jo Armes and Lisa Stubbs and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

M L Slevin

106 papers receiving 4.6k citations

Hit Papers

Attitudes to chemotherapy: comparing views of patients wi... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers

M L Slevin
Comparison fields: 5 of 139
  • Oncology 1.8k
  • Molecular Biology 1.1k
  • Public Health, Environmental and Occupational Health 785
  • Surgery 652
  • Pulmonary and Respiratory Medicine 628
Replace Simon Van Belle with:
Simon Van Belle Belgium
L. Douglas Case United States
Celeste Lindley United States
Michael S. Rogers Hong Kong
Oriana Nanni Italy
John A. Levi Australia
Gregory A. Curt United States
Karin Jordan Germany
Auro del Giglio Brazil
Mikael Rørth Denmark
Simon Van Belle Belgium View profile →
Citations per field, relative to M L Slevin
M L Slevin · 1×
Citations per year, relative to M L Slevin
M L Slevin · 1×

Countries citing papers authored by M L Slevin

Since Specialization
Citations

This map shows the geographic impact of M L Slevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M L Slevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M L Slevin more than expected).

Fields of papers citing papers by M L Slevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M L Slevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M L Slevin. The network helps show where M L Slevin may publish in the future.

Co-authorship network of co-authors of M L Slevin

This figure shows the co-authorship network connecting the top 25 collaborators of M L Slevin. A scholar is included among the top collaborators of M L Slevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M L Slevin. M L Slevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 14
2 38
3 74
4 3
5 19
6 131
7 48
8 116
9
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. breakdown →
555
10 343
11 10
12 36
13
A Randomized Double-Blind Placebo Controlled Trial of Medroxyprogesterone Acetate (Mpa) in Cancer Cachexia
5
14 49
15 5
16
Pharmacokinetics and tumour uptake of radio-labelled tumour associated monoclonal antibodies instilled intraperitoneally in patients with ovarian and colon cancers
1
17
High-dose etoposide in the treatment of relapsed primary brain tumors.
20
18 4
19 56
20 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026